CLS (LON:CLI) Reaches New 12-Month High at $294.50

CLS Holdings plc (LON:CLI)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 294.50 ($3.85) and last traded at GBX 294.50 ($3.85), with a volume of 25 shares trading hands. The stock had previously closed at GBX 290 ($3.79).

CLI has been the subject of several research analyst reports. Berenberg Bank restated a “buy” rating and set a GBX 275 ($3.59) price objective on shares of CLS in a research report on Thursday, September 5th. Liberum Capital reaffirmed a “buy” rating on shares of CLS in a report on Wednesday, November 20th. Finally, Peel Hunt reaffirmed a “buy” rating on shares of CLS in a report on Tuesday.

The firm has a 50 day moving average of GBX 260.79 and a two-hundred day moving average of GBX 236.98. The firm has a market capitalization of $1.17 billion and a price-to-earnings ratio of 8.98. The company has a quick ratio of 1.05, a current ratio of 2.18 and a debt-to-equity ratio of 82.33.

In related news, insider Bengt F. Mortstedt sold 172,045 shares of the stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of GBX 261 ($3.41), for a total value of £449,037.45 ($586,746.96). Also, insider Bengt F. Mortstedt sold 322,150 shares of the firm’s stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of GBX 259 ($3.38), for a total transaction of £834,368.50 ($1,090,250.23).

About CLS (LON:CLI)

CLS Holdings plc, together with its subsidiaries, engages in the investment, development, and management of commercial properties in the United Kingdom, France, Germany, and France. It operates in two segments, Investment Property and Other Investments. The company also invests a hotel; and corporate bonds, shares, and other corporate investments.

Further Reading: What is a growth and income fund?

Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.